Perioperative intravenous fluid and chronic kidney disease: long-term follow-up of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery (RELIEF) randomised trial
British Journal of Anaesthesia · 2026-08 · 137 (2) · 479-489
DOI: 10.1016/j.bja.2026.05.010 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Anaesthesia, 2026-08. Verfasst von David R McIlroy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Anaesthesiology and Perioperative Medicine, Mon…. Hauptthemen laut MEDLINE: Fluid Therapy, Renal Insufficiency, Chronic, Acute Kidney Injury, Abdomen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Monash University, National Health and Medical Research Council, NIHR Biomedical Research Unit.
Abstract (Originalsprache)
BACKGROUND: The Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery (RELIEF) randomised trial found that a restrictive intravenous fluid regimen increased the risk of acute kidney injury (AKI) after major abdominal surgery. We examined whether AKI after restrictive fluid therapy increased the risk for chronic kidney disease (CKD). METHODS: We conducted long-term follow-up between 90 days and 48 months after surgery in RELIEF participants randomly assigned to a restrictive vs liberal fluid regimen, from May 2013 through September 2016. The primary outcome was incident or progressive CKD (stage ≥3), including worsening by ≥1 CKD stage in participants with preoperative CKD stage ≥3. Secondary outcomes included lowest recorded estimated glomerular filtration rate (eGFR) and maximal change in eGFR from baseline. RESULTS: Long-term follow-up data were obtained for 1670/2983 participants (mean age 69 (range: 58-75)yr; 47% females) included in the modified intention-to-treat analysis of the original RELIEF trial. The primary analysis was performed for 754 (49.6%) assigned to a restrictive fluid regimen and 766 (50.4%) assigned to a liberal fluid regimen. The incidence of new or worse CKD ≥ stage 3 did not differ between 422/754 (56%) participants assigned to restrictive fluid therapy, compared with 409/766 (53.4%) participants who received liberal fluid therapy (adjusted odds ratio 1.13 [95% CI 0.91-1.41]). These findings remained unaltered in sensitivity analyses. There were also no differences for eGFR secondary outcomes. CONCLUSIONS: Within the limits of this post hoc analysis, no difference was found in the incidence of new or progressive CKD was not related to a restrictive perioperative fluid regimen. TRIAL REGISTRATION: ClinicalTrials.gov (NCT01424150).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Anaesthesiology and Perioperative Medicine, Monash University, Melbourne, VIC, Australia. Electronic address: david.r…
- Department of Anaesthesiology and Perioperative Medicine, Monash University, Melbourne, VIC, Australia; Department of Anaesthesia and Perioperative Medicine, Alfred Health, Melbourne, VIC, Australia.
- Department of Biostatistics, Monash University, Melbourne, VIC, Australia.
- Department of Critical Care, Melbourne Medical School, University of Melbourne, Austin Hospital, Melbourne, VIC, Australia; Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.
- Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia; Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.
- Department of Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, WA, Australia; School of Medicine and Pharmacology University of Western Australia, Perth, WA, Australia; School of Public Health and Preventive…
Förderung
- Monash University
- National Health and Medical Research Council
- NIHR Biomedical Research Unit
- National Institute for Health and Care Research
- Health Research Council of New Zealand
- Australian and New Zealand College of Anaesthetists
Zitieren
APA
McIlroy, D. R., Wallace, S. K., Forbes, A., Peyton, P., Story, D. A., Corcoran, T., Neto, A. S., & Myles, P. S. (2026). Perioperative intravenous fluid and chronic kidney disease: long-term follow-up of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery (RELIEF) randomised trial. British Journal of Anaesthesia, 137(2), 479-489. https://doi.org/10.1016/j.bja.2026.05.010
Vancouver
McIlroy DR, Wallace SK, Forbes A, Peyton P, Story DA, Corcoran T, et al. Perioperative intravenous fluid and chronic kidney disease: long-term follow-up of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery (RELIEF) randomised trial. British Journal of Anaesthesia. 2026;137(2):479-489. doi:10.1016/j.bja.2026.05.010
BibTeX
@article{McIlroy2026,
author = {McIlroy, David R and Wallace, Sophia K and Forbes, Andrew and Peyton, Philip and Story, David A and Corcoran, Tomas and Neto, Ary Serpa and Myles, Paul S},
title = {Perioperative intravenous fluid and chronic kidney disease: long-term follow-up of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery (RELIEF) randomised trial},
journal = {British Journal of Anaesthesia},
year = {2026},
volume = {137},
number = {2},
pages = {479--489},
doi = {10.1016/j.bja.2026.05.010}
}
EUVIMED